Enter inventor name

Howard Tucker

USPTO Granted Patents = 26 (Patent Applications = 1)

EPO Patents = 2

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 433(Granted Patents)

Location History:

Macclesfield, EN (1978)
Cheshire, GB (2006 - 2008)
Macclesfield, GB (1980 - 2009)

Company Filing History:

12 out of 3,840

Imperial Chemical Industries Limited

Years Active: 1978-2009

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7615555 - Piperidine derivatives as modulators of chemokine receptor CCR5 (2009-11-10),

2. 7342020 - Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) (2008-03-11),

3. 7192973 - Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) (2007-03-20),

4. 7153857 - Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents (2006-12-26),

5. 7122551 - Metalloproteinase inhibitor compounds (2006-10-17),

6. 6916817 - Inhibitors of metalloproteinases (2005-07-12),

7. 6787562 - Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists (2004-09-07),

8. 6734184 - Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) (2004-05-11),

9. 6734183 - Compounds (2004-05-11),

10. 6057345 - Substituted aryl and heteroaryl compounds as E-type prostaglandin (2000-05-02),

11. 5965741 - Ortho-substituted aromatic ether compounds and their use in (1999-10-12),

12. 5843942 - Aromatic amino ethers as pain relieving agents (1998-12-01),

13. 5834468 - Substituted aryl and heteroaryl compounds as E-type prostaglandin (1998-11-10),

14. 5811459 - Ortho substituted aromatic compounds useful as antagonists of the pain (1998-09-22),

15. 5317101 - Tricyclic heterocycles (1994-05-31),

Title: Howard Tucker: Innovator in Pharmaceutical Patents

Introduction

Howard Tucker, a prominent inventor located in Macclesfield, GB, has made significant contributions to the field of pharmaceuticals, with a remarkable portfolio of 26 patents. His innovative work focuses on developing novel compounds and processes aimed at advancing medical therapies.

Latest Patents

One of Howard Tucker's latest patents involves piperidine derivatives as modulators of the chemokine receptor CCR5. This patent, which details compounds of formula (I), encompasses compositions that include these compounds, processes for their preparation, and their applications in medical therapy, specifically aimed at modulating CCR5 receptor activity in warm-blooded animals.

Another significant patent granted to Tucker covers arylpiperazines as metalloproteinase inhibiting agents. This invention features arylpiperazines of formula (I) that serve as inhibitors, particularly focusing on MMP-13, demonstrating his expertise in creating valuable pharmaceutical agents.

Career Highlights

Throughout his career, Howard Tucker has been associated with respected companies such as Imperial Chemical Industries Limited and AstraZeneca AB. His work in these leading institutions has enabled him to advance his research and development endeavors, solidifying his role as a crucial innovator in the pharmaceutical sector.

Collaborations

In addition to his achievements, Tucker has collaborated with notable professionals in the industry including John Oldfield and Peter Warner. These partnerships have contributed to the successful development of his patented inventions and the advancement of pharmaceutical research.

Conclusion

With 26 patents to his name, Howard Tucker continues to lead innovative efforts in the pharmaceutical field, particularly focusing on compounds that have the potential to revolutionize therapeutic practices. His contributions through extensive research and collaborations mark him as a notable figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com